This paper is in the following e-collection/theme issue:

mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1290) Patient-Reported Outcome Measures (PROMs) (272) mHealth for Treatment Adherence (381) Innovations and Technology in Cancer Care (396) Mobile Apps for Cancer Care and Cancer Prevention and Screening (196)

Published on in Vol 8, No 10 (2020): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/20480, first published .
Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study

Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study

Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study

Authors of this article:

Roberto Collado-Borrell1 Author Orcid Image ;   Vicente Escudero-Vilaplana1 Author Orcid Image ;   Almudena Ribed1 Author Orcid Image ;   Cristina Gonzalez-Anleo2 Author Orcid Image ;   Maite Martin-Conde2 Author Orcid Image ;   Rosa Romero-Jimenez1 Author Orcid Image ;   Irene Iglesias-Peinado3 Author Orcid Image ;   Ana Herranz-Alonso1 Author Orcid Image ;   Maria Sanjurjo-Saez1 Author Orcid Image
Article Authors Cited by (7) Tweetations (5) Metrics

Journals

  1. Karaaslan-Eşer A, Ayaz-Alkaya S. The effect of a mobile application on treatment adherence and symptom management in patients using oral anticancer agents: A randomized controlled trial. European Journal of Oncology Nursing 2021;52:101969 View
  2. Romero-Jimenez R, Escudero-Vilaplana V, Chamorro-de-Vega E, Ais-Larisgoitia A, Lobato-Matilla E, Somoza-Fernández B, Ruiz-Briones P, González C, Baniandrés O, Menchén L, Lobo-Rodríguez C, Herranz A, Sanjurjo M. Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare. Frontiers in Immunology 2022;13 View
  3. Narrillos-Moraza Á, Gómez-Martínez-Sagrera P, Amor-García M, Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Gómez-Centurión I, Herranz-Alonso A, Sanjurjo-Sáez M. Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale. JMIR mHealth and uHealth 2022;10(2):e32826 View
  4. Collomb B, Dubromel A, Caffin A, Herledan C, Larbre V, Baudouin A, Cerutti A, Couturier L, Maire M, Karlin L, Maucort-Boulch D, Huot L, Dalle S, Bachy E, Ghesquieres H, Salles G, Couraud S, You B, Freyer G, Trillet-Lenoir V, Ranchon F, Rioufol C. Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program. Cancers 2022;14(3):660 View
  5. Ardito V, Golubev G, Ciani O, Tarricone R. Evaluating Barriers and Facilitators to the Uptake of mHealth Apps in Cancer Care Using the Consolidated Framework for Implementation Research: Scoping Literature Review. JMIR Cancer 2023;9:e42092 View
  6. Aboye G, Vande Walle M, Simegn G, Aerts J. mHealth in sub-Saharan Africa and Europe: A systematic review comparing the use and availability of mHealth approaches in sub-Saharan Africa and Europe. DIGITAL HEALTH 2023;9 View
  7. Faezi A, Afshar H, Rahimi B. Identifying factors that affect the use of health information technology in the treatment and management of hypertension. BMC Medical Informatics and Decision Making 2023;23(1) View